# Howard Rosen

> Howard Rosen is the CEO and co-founder of Evident Vascular, a San Jose medtech startup building an AI-powered intravascular ultrasound (IVUS) platform for peripheral and coronary interventions. A 30-year cardiovascular device veteran, he spent 21 years at Boston Scientific before helping guide Intact Vascular and its spinout Vesper Medical through acquisitions by Philips. He launched Evident out of stealth in 2023 with a $35 million Series A led by Vensana Capital and closed a Series B in 2025. He is known for a disciplined 'go slow to go fast' company-building philosophy.

- **Role:** Chief Executive Officer & Co-Founder at Evident Vascular
- **Organizations:** Evident Vascular, Inc., Intact Vascular, Vesper Medical, Haemonetics, BG Medicine, Boston Scientific
- **Nationality:** American
- **Education:** B.S. in Business Administration, Northeastern University
- **Known for:** Co-founded and leads Evident Vascular, an AI-powered IVUS platform company, Raised a $35 million Series A led by Vensana Capital and later a Series B round, Guided Intact Vascular through its 2020 acquisition by Royal Philips

## Career timeline

- **1980s-2000s** — Spent 21 years at Boston Scientific, starting as a Territory Sales Manager and advancing through marketing leadership in peripheral vascular and cardiovascular business units
- **2010s** — VP of Sales and Marketing at BG Medicine, a Flagship Pioneering company
- **2010s** — VP of the Blood Collections Business Unit at Haemonetics
- **2020** — As Head of Intact Vascular, integrated the company following its acquisition by Royal Philips
- **2022** — Held VP of Marketing and Business Development for Vesper Medical, an Intact Vascular spinout, which was acquired by Royal Philips
- **2023** — Co-founded Evident Vascular and exited stealth on October 17, 2023 with a $35M Series A led by Vensana Capital
- **2025** — Closed Series B financing (announced March 25, 2025) with new investors Shangbay Capital and two undisclosed strategics, alongside founding investor Vensana Capital

## Achievements

- Co-founded and leads Evident Vascular, an AI-powered IVUS platform company
- Raised a $35 million Series A led by Vensana Capital and later a Series B round
- Guided Intact Vascular through its 2020 acquisition by Royal Philips
- Held leadership over Vesper Medical through its 2022 acquisition by Royal Philips
- Built a 30-year career across emerging and mature cardiovascular device companies with record revenues and new product commercializations

## Latest updates

- **2025-03** — Evident Vascular closed its Series B financing with new investors Shangbay Capital and two undisclosed strategics joining founding investor Vensana Capital, funding next-gen IVUS development and the path to FDA 510(k) clearance.
- **2025-08** — Rosen appeared on the Medsider podcast discussing disciplined medtech company building.

## Links

- Website: https://evidentvascular.com
- LinkedIn: http://www.linkedin.com/in/howardmrosen

---

Profile page: https://yespress.io/howard-rosen
Published by YesPress — https://yespress.io
Last updated: 2026-07-17